drugset / Trial / NCT06769074
Assessment of Platelet Rich Plasma Injection in Managing Female Patients Complaining of Mixed Urinary Incontinence (PRP)
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to assess the efficacy of platelet-rich plasma (PRP) for the treatment of mixed urinary incontinence determine .The main question it aims to answer whether PRP is it safe and effective in managing mixed urinary incontinence? Researchers will assess efficacy of PRP in both stress and urgency incontinence treatment Participants will: * Undergo PRP injection in to mid urethra , and installation into bladder every 1 month for 3 month * Visit the clinic once every 1 month for checkups and urodynamic study after 3 month, and 4 month after last installation
Timeline
- Start
- 2024-12-28
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | 1.5 ml | Other |
| Subject | Platelet Rich Plasma | Other / unclassified | 2 ml | Other |
| Subject | Platelet Rich Plasma | Other / unclassified | 10 ml | Other |